ClinicalTrials.govpublic full text
Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease
t2dm (type 2 diabetes mellitus), masld - metabolic dysfunction-associated steatotic liver disease, metabolic syndrome (mets), interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873123
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.